Pellagatti, A., Jadersten, M., Forsblom, A., Cattan, H., Christensson, B., Emanuelsson, E., . . . Hellstrom-Lindberg, E. (2006). Lenalidomide up-regulates SPARC and inhibits in vitro growth of the malignant clone in myelodysplastic syndrome patients with 5q deletion.
Cita Chicago (17th ed.)Pellagatti, A., et al. Lenalidomide Up-regulates SPARC and Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome Patients with 5q Deletion. 2006.
Cita MLA (9th ed.)Pellagatti, A., et al. Lenalidomide Up-regulates SPARC and Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome Patients with 5q Deletion. 2006.
Atenció: Aquestes cites poden no estar 100% correctes.